OBJECTIVE: Tumor necrosis factor-a (TNF-a) is expressed primarily in adipocytes, and elevated levels of this cytokine have been linked to obesity and insulin resistance. Recently, the A allele of a polymorphism in the 5
Introduction
Obesity is increasing in prevalence and is associated with several adverse health problems, including type 2 diabetes, hyperlipidemia and hypertension. 1 The in¯uence of obesity on the development of obesity-related disorders is complex and probably due to an interaction of genetic, nutritional and metabolic factors. 2, 3 Tumor necrosis factor-a (TNF-a), a cytokine expressed primarily in adipocytes, where it is an important modulator of gene expression, 4 ± 6 is a putative candidate gene for obesity and obesity-related disorders. TNF-a affects lipid metabolism and may lead to hypertriglyceridemia by decreasing lipoprotein lipase activity 7 and increasing hepatic de novo fatty acid synthesis. 8 Furthermore, TNF-a may affect carbohydrate metabolism by decreasing both the insulinstimulated autophosphorylation and tyrosine kinase activity of the insulin receptor in muscle and adipose tissue. 9, 10 In obese individuals, TNF-a expression is elevated and has been reported to correlate with hyperinsulinemia. 5 Recently, a biallelic variant was identi®ed in the 5 H regulatory region of the TNF-a gene at position 7308 (guanine (G) adenine (A)) from the start site of transcription which may increase expression of this cytokine in fat tissue.
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Preliminary evidence from a study by Ferna Ândez-Real et al 12 in 38 subjects (19 men, 19 women) suggested an association of this polymorphism with increased insulin resistance, body fat and serum leptin levels. The purpose of our study was, therefore, to examine the relationship of the TNF-a variant to traits related to obesity and insulin resistance in a larger group of Caucasian subjects.
Subjects and methods

Subjects
A total of 176 subjects (men, n 50; women, n 126) of Caucasian origin, with a wide range of body weight (body mass index (BMI) range: 20.2 ± 54.9 kgam 2 ), with and without hypertension andaor impaired glucose tolerance, who responded to an advertisement within the university campus, were recruited within the framework of the BErG (Berlin Erna Èhrung Geschwister) Study.
Patients with diabetes mellitus, congestive heart failure, abnormal renal or liver function, and intentional weight reduction during the last 3 months were excluded from the study. Impaired glucose tolerance was determined by an oral glucose tolerance test (OGTT; Dextro 1 O.G-T., Hoffmann-La Roche AG, Grenzach-Wyhlen, Germany). 13 Hypertension was de®ned as a 24-h ambulatory blood pressure level b 135a85 mmHg (Spacelabs 90207) 14 andaor the intake of antihypertensive medication. Patients were also assessed for the intake of thyroid hormones and other medication.
The study protocol was approved by the institutional Ethics Committee and all subjects gave informed consent before participating in the study.
Study protocol and methods
All subjects were characterized for weight, heightaand waistto-hip ratio (WHR). Body composition was determined by bioelectrical impedance analysis (AKERN-RJL BIA 101aS, Frankfurt a. M., Germany). 15 Following the insertion of a venous cannula in the recumbent, fasting subject blood samples were collected for the measurements of glucose and insulin. An oral glucose tolerance test (OGTT, 75 g glucose) was then performed 13 with collection of blood samples for insulin and glucose measurements at 60 and 120 min.
Analytical methods
Plasma glucose was measured by a glucose analyzer (Beckman Instruments GmbH, Munich, Germany), and plasma insulin by radioimmunoassay (Biermann, Bad Nauheim, Germany). Area under the curve (AUC) was calculated for glucose and insulin response during OGTT by the trapezoidal rule. Analyses of plasma leptin and angiotensinogen were also done as described previously. 16 Triglycerides and cholesterol were measured by commercial kits (Boehringer Mannheim, Mannheim, Germany).
Statistical analysis
Statistical analysis was performed on 176 unrelated subjects using the SPSS-PC software package (SPSS Inc., Chicago, IL, USA).
Differences between groups were tested for signi®cance by two-tailed Student's t test for independent samples or the nonparametric Mann ± Whitney U-test as appropriate. w 2 statistics were used to detect differences in the distribution between men and women, BMI quartiles, impaired and normal glucose tolerance, and subjects with and without medication. Stepwise multivariate regression analysis was performed to explore the dependence of G7308A genotypes on sex, age, body composition, insulin, glucose, leptin and angiotensinogen. Data are presented as means AE s.d. or median and range (minimumamaximum) as appropriate. Differences and correlations were considered signi®cant at P`0.05.
Genotyping
Genomic DNA was prepared from peripheral blood using a DNA-selective preparation method (QIAGEN, Hilden, Germany). The genomic region encompassing the biallelic polymorphism (G7308A) was ampli®ed by using oligonucleotide primers (forward primer: 5 H AGG CAA TAG GTT TTG AGG GCC AT 3 H ; reverse primer: 5 H TCC TCC CTG CTC CGA TTC CG 3 H ) and PCR conditions as described previously. 11 PCR products were digested by addition of 1 U of NcoI restriction enzyme for 3 h at 37 C. The 7308A allele lacks a NcoI restriction site present in the 7308G allele, so that the PCR product (107 bp) was cut into two fragments of 80 and 27 bp in length, visualized on ethidium bromide-stained 3% agarose gels only in the presence of the 7308A allele.
Results
Clinical characteristics with several obesity-related parameters including BMI, WHR, body composition, as well as blood pressure levels and heart rate for each genotypic group are presented in Table 1 . The genotype frequencies did not deviate from Hardy ± Weinberg equilibrium, and the frequency of the G allele (0.18) was similar to that described in a previous study (0.17) in Caucasians. 17 To examine whether the variant alleles were more common in patients with morbid obesity, we strati®ed the BErG participants by BMI quartiles (I,`27. , in each quartile n 44; Table 2 ). w 2 analyses revealed a signi®cant difference in gene frequencies across the four grades of BMI (all groups P 0.013; extremes (IaIV) P 0.009, w 2 10.8, OR 3.29, Figure 1 ).
Regression analysis with adjustment for age, BMI and sex revealed no signi®cant differences in the BErG participants among genotypes for fasting glucose levels, fasting insulin levels or glucose and insulin response during OGTT (data not Tumor necrosis factor-a gene and obesity E Brand et al shown). Likewise, none of the plasma parameters were related to the polymorphism (data not shown).
Discussion
The main ®nding of our study was a signi®cantly higher frequency of the TNF-a 7308A allele in the highest BMI quartile ( b 36.5 kgam 2 ) of our study population. This observation is in line with previous data from Herrmann et al 18 who reported that the TNF-a 7308A allele was more common in obese than in non-obese subjects in the ECTIM Study, a case ± control study on myocardial infarction in patients recruited from France and Northern Ireland. More recently, Hoffstedt et al 19 also reported an association between this genetic marker and excessive fat accumulation in women. A potential role for the TNF-a locus in obesity is also supported by a linkage study, which reported a relationship between the TNF-a locus and various global measures of adiposity in Pima Indians and European Caucasians. 12, 20 Thus, our data support the hypothesis that a genetic variant of the TNF-a gene may contribute to the development of obesity.
The functional role of the TNF-a-G 7308A polymorphism is currently unclear. However, its location within a consensus sequence for the transcription factor AP-2 in the promoter region of the gene 11 and the association of this variant with higher constitutive and inducible levels of TNF-a gene transcription in adipose tissue 21 suggests that this variant could play a role in the development of obesity and related phenotypes. 4 Interestingly, obesity is known to be associated with increased levels of TNF-a mRNA and protein in fat tissue both in humans 5 and in genetically obese or diabetic rodents. 22 Furthermore, Kern et al 23 have shown that the TNF-a mRNA level in adipose tissue is signi®cantly correlated with the percentage body fat in human obese subjects.
A recent report by Ferna Ândez-Real et al 12 also found a signi®cant association between the TNF-a 7 308A allele and plasma leptin levels, a ®nding that is of interest, as Kirchgessner et al 24 have suggested that leptin expression and secretion may be regulated by TNF-a in cultured adipocytes. Tumor necrosis factor-a gene and obesity E Brand et al
While leptin levels were in fact higher (as expected) in the subjects within the highest BMI quartile, the relationship between the TNF-a 7G308A genotype and plasma leptin levels failed to reach statistical signi®cance. Hamann et al 25 did not ®nd any difference in allele frequencies of the TNF-a G7308A and G7238A polymorphisms between non-insulin dependent diabetes mellitus (NIDDM) patients and unrelated controls. Likewise, in our study, we found no relationship between the G ± 308A polymorphism and plasma glucose and insulin response to an OGTT, suggesting that, despite its relationship to obesity, this variant may not be an important determinant of insulin resistance.
In a recent study, while con®rming linkage between the TNF-a locus and obesity in families of French-Canadian origin, Pausova et al 26 also found a signi®cant association between this locus and high blood pressure. A signi®cant positive correlation between serum TNF-a concentration and systolic blood pressure has also been reported among individuals of an isolated native Canadian population over a wide range of adiposity. 27 TNF-a may indeed contribute to the development of hypertension, as it is known to stimulate the production of a potent vasoconstrictor endothelin-1 in vascular smooth muscle cells 28 as well as the renin substrate angiotensinogen in adipose tissue. 29 In our study, however, we found no evidence to support a relationship between blood pressure and the TNF-a 7308A allele.
In summary, in the present study we found a relationship between the TNF-a 7G308A polymorphism and BMI in Caucasian subjects. These ®ndings support the hypothesis that the TNF-a 7G308A polymorphism may serve as a genetic marker for obesity in Caucasians and points to a pathogenic role for this gene in the development of obesity in this population.
